Gabapentin Immunoassay Antibody Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for therapeutic drug monitoring of gabapentin are impractical due to their labor-intensive, costly, and time-consuming nature, which limits their effectiveness in achieving consistent clinical outcomes and managing variability in drug concentrations among individuals.
Innovation Solution
A method and compound for detecting gabapentin using a specific antibody and gabapentin conjugate, allowing for the formation of a complex that can be easily detected, facilitating quantitative measurement of gabapentin levels in samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If chromatographic techniques are used to determine gabapentin levels, then measurement precision is improved, but productivity deteriorates due to long sample preparation time, long assay time, and labor-intensive procedures
Solution Approach 1:
The patent replaces mechanical chromatographic separation systems with an immunoassay system that uses antibody-antigen recognition. This substitution eliminates the need for complex chromatographic equipment, sample preparation steps, and long assay times while maintaining measurement accuracy through specific immunological binding.
Solution Approach 2:
The patent introduces an antibody as an intermediary substance that specifically binds to gabapentin. This antibody mediator enables direct detection of gabapentin levels without requiring chromatographic separation, thereby improving productivity while maintaining measurement precision through the high specificity of immunological binding.
2Measurement precision
If chromatographic techniques are used to determine gabapentin levels, then measurement precision is improved, but device complexity increases due to labor-intensive procedures
Solution Approach 1:
The patent replaces complex mechanical chromatographic systems with a simpler immunoassay system based on antibody-antigen binding. This substitution reduces device complexity and eliminates labor-intensive procedures while preserving measurement precision through the inherent specificity of immunological interactions.
Solution Approach 2:
The antibody in the immunoassay system performs the separation and detection function automatically through specific binding to gabapentin, eliminating the need for complex mechanical separation equipment and manual操作流程. The system serves itself by using biological recognition to achieve both simplicity and precision.
3Measurement precision
If chromatographic techniques are used to determine gabapentin levels, then measurement precision is improved, but loss of time increases due to long sample preparation time and long assay time
Solution Approach 1:
The patent replaces time-consuming mechanical chromatographic procedures with rapid immunoassay methods. The antibody-based detection system eliminates lengthy sample preparation and separation steps, reducing total assay time while maintaining measurement precision through specific immunological binding.
Solution Approach 2:
The immunoassay system is designed with pre-formed antibody reagents that are ready for immediate use, eliminating the need for time-consuming sample preparation and chromatographic column conditioning. The preliminary preparation of antibody-based detection reagents enables rapid analysis while maintaining precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables efficient and accurate monitoring of gabapentin levels, allowing for personalized dosing and improved therapeutic management by reducing variability and side effects.
Implementation Method 1
adding, to a reaction mixture, (i) a sample suspected of containing gabapentin and (ii) an anti-gabapentin antibody capable of forming of a complex of gabapentin that may be present in the sample and the antibody
Data Source
AI summary
Compounds and methods for use in detecting gabapentin in a sample suspected of containing gabapentin are disclosed. Gabapentin derivatives are used to produce gabapentin conjugates. A gabapentin-immunogenic carrier conjugate may be used as an immunogen for the preparation of an anti-gabapentin antibody. A gabapentin-detectable label may be used in a signal producing system in gabapentin assays.


